These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 12446975)

  • 61. Experimental brain inflammation and neurodegeneration as model of Alzheimer's disease: protective effects of selective COX-2 inhibitors.
    Giovannini MG; Scali C; Prosperi C; Bellucci A; Pepeu G; Casamenti F
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):31-40. PubMed ID: 14552702
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cyclooxygenase and Alzheimer's disease: implications for preventive initiatives to slow the progression of clinical dementia.
    Pasinetti GM
    Arch Gerontol Geriatr; 2001 Aug; 33(1):13-28. PubMed ID: 11461718
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and reality.
    Rüegg C; Zaric J; Stupp R
    Ann Med; 2003; 35(7):476-87. PubMed ID: 14649330
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease.
    Blasko I; Grubeck-Loebenstein B
    Drugs Aging; 2003; 20(2):101-13. PubMed ID: 12534311
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Alzheimer's disease, inflammation and non-steroidal anti-inflammatory drugs.
    Ferencik M; Novak M; Rovensky J; Rybar I
    Bratisl Lek Listy; 2001; 102(3):123-32. PubMed ID: 11433600
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anti-inflammatory drugs and their mechanism of action.
    Vane JR; Botting RM
    Inflamm Res; 1998 Oct; 47 Suppl 2():S78-87. PubMed ID: 9831328
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mechanism of action of antiinflammatory drugs.
    Vane JR; Botting RM
    Int J Tissue React; 1998; 20(1):3-15. PubMed ID: 9561441
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Selective inhibition of Abeta42 production by NSAID R-enantiomers.
    Morihara T; Chu T; Ubeda O; Beech W; Cole GM
    J Neurochem; 2002 Nov; 83(4):1009-12. PubMed ID: 12421374
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ibuprofen and Alzheimer's disease.
    Dokmeci D
    Folia Med (Plovdiv); 2004; 46(2):5-10. PubMed ID: 15506544
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's disease.
    Wilkinson BL; Cramer PE; Varvel NH; Reed-Geaghan E; Jiang Q; Szabo A; Herrup K; Lamb BT; Landreth GE
    Neurobiol Aging; 2012 Jan; 33(1):197.e21-32. PubMed ID: 20696495
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects?
    Giovanni G; Giovanni P
    J Nephrol; 2002; 15(5):480-8. PubMed ID: 12455713
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Disease-modifying therapies in Alzheimer's disease: how far have we come?
    Hüll M; Berger M; Heneka M
    Drugs; 2006; 66(16):2075-93. PubMed ID: 17112302
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease.
    Pinnen F; Sozio P; Cacciatore I; Cornacchia C; Mollica A; Iannitelli A; D'Aurizio E; Cataldi A; Zara S; Nasuti C; Di Stefano A
    Arch Pharm (Weinheim); 2011 Mar; 344(3):139-48. PubMed ID: 21384412
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease.
    Sung S; Yang H; Uryu K; Lee EB; Zhao L; Shineman D; Trojanowski JQ; Lee VM; Praticò D
    Am J Pathol; 2004 Dec; 165(6):2197-206. PubMed ID: 15579461
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of cyclo-oxygenase 1 and 2 activity in prostaglandin E(2) secretion by cultured human adult microglia: implications for Alzheimer's disease.
    Hoozemans JJ; Veerhuis R; Janssen I; van Elk EJ; Rozemuller AJ; Eikelenboom P
    Brain Res; 2002 Oct; 951(2):218-26. PubMed ID: 12270500
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells.
    Blasko I; Apochal A; Boeck G; Hartmann T; Grubeck-Loebenstein B; Ransmayr G
    Neurobiol Dis; 2001 Dec; 8(6):1094-101. PubMed ID: 11741404
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
    Crew TE; Elder DJ; Paraskeva C
    Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736
    [TBL] [Abstract][Full Text] [Related]  

  • 78. NSAIDs as potential treatment option for preventing amyloid β toxicity in Alzheimer's disease: an investigation by docking, molecular dynamics, and DFT studies.
    Azam F; Alabdullah NH; Ehmedat HM; Abulifa AR; Taban I; Upadhyayula S
    J Biomol Struct Dyn; 2018 Jun; 36(8):2099-2117. PubMed ID: 28571516
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Trends in nonsteroidal anti-inflammatory drug development and application].
    Miedzybrodzki R
    Postepy Hig Med Dosw (Online); 2004; 58():438-48. PubMed ID: 15577751
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Triptolide Rescues Spatial Memory Deficits and Amyloid-β Aggregation Accompanied by Inhibition of Inflammatory Responses and MAPKs Activity in APP/PS1 Transgenic Mice.
    Cui YQ; Wang Q; Zhang DM; Wang JY; Xiao B; Zheng Y; Wang XM
    Curr Alzheimer Res; 2016; 13(3):288-96. PubMed ID: 26906357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.